[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370396-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370396-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mettl3-dependent-m6a-methylation-of-circceacam5-fuels-pancreatic-cancer-progression-through-dkc1-activation","METTL3-dependent m6A methylation of circCEACAM5 fuels pancreatic cancer progression through DKC1 activation","","Pancreatic cancer is a highly lethal disease with poor prognosis, and growing evidence links circular RNAs and m6A methylation to tumor progression. The study investigates how METTL3-dependent m6A methylation regulates circCEACAM5 in pancreatic cancer and how circCEACAM5 engages downstream effectors, focusing on DKC1 activation. Experimental analyses combine RT-qPCR, Sanger sequencing, stability tests, FISH, functional assays, in vivo tumor models, and m6A-specific immunoprecipitation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mettl3-dependent-m6a-methylation-of-circceacam5-fuels-pancreatic-cancer-progression-through-dkc1-activation/370396/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mettl3-dependent-m6a-methylation-of-circceacam5-fuels-pancreatic-cancer-progression-through-dkc1-activation/370396.png","ImageObject",300,407,{"name":42,"@type":43},"Aurelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does circCEACAM5 play in pancreatic cancer progression?","Question",{"text":63,"@type":64},"circCEACAM5 is significantly upregulated in pancreatic cancer and is associated with poor clinical outcomes. It promotes proliferation, invasion, and migration while inhibiting apoptosis in vitro and in vivo.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is circCEACAM5 regulated at the epigenetic level in this study?",{"text":68,"@type":64},"METTL3-mediated m6A methylation of circCEACAM5 was confirmed. METTL3 knockdown reverses the malignant effects caused by circCEACAM5 silencing.",{"name":70,"@type":61,"acceptedAnswer":71},"How does DKC1 fit into the circCEACAM5 mechanism?",{"text":72,"@type":64},"circCEACAM5 interacts with DKC1. DKC1 overexpression reverses the effects of circCEACAM5 knockdown on malignant behaviors of pancreatic cancer cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370396,1790460919,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Cellular and Molecular Life Sciences (2025) 82:132  \n[https://doi.org/10.1007/s00018-025-05653-5](https://doi.org/10.1007/s00018-025-05653-5) Cellular and Molecular Life Sciences  \nMETTL3‑dependent m6A methylation ofcircCEACAM5 fuels pancreatic cancer progression through DKC1 activation  \nJie Zhang1 · Wenxue Sun2 · Wenda Wu3 · Zihui Qin3 · Ben Wei3 · Tushuai Li1  \nReceived: 14 November 2024 / Revised: 20 February 2025 / Accepted: 7 March 2025 © The Author(s) 2025  \nAbstract  \nBackground Pancreatic cancer is highly lethal and has a poor prognosis. Research has highlighted the role of circular RNAsand m6A methylation in cancer progression. METTL3, a key m6A methyltransferase, is linked to various cancers, but its interaction with circular RNAs in pancreatic cancer is unclear. This study examined the role of circCEACAM5 in pancreatic cancer, particularly its regulation by METTL3-mediated m6A methylation and interaction with effectors such as DKC1 . Methods circCEACAM5 expression in pancreatic cancer tissues and cell lines was evaluated via RT‒qPCR. Its characteristics were validated through Sanger sequencing, stability assays, and FISH. Functional assays (CCK-8, EdU, Transwell, and flow cytometry) were conducted in AsPC-1 cells, and in vivo tumor models were established. m6A modification was analyzed via bioinformatics tools and m6A-specific immunoprecipitation, while RNA pull-down assays were used to examine the interaction of circCEACAM5 with METTL3 and DKC1 .  \nResults circCEACAM5 was significantly upregulated in pancreatic cancer and correlated with poor clinical outcomes. CircCEACAM5 promoted cell proliferation, invasion, and migration while inhibiting apoptosis both in vitro and in vivo. METTL3-mediated m6A methylation of circCEACAM5 was confirmed, and METTL3 knockdown reversed the effects ofcircCEACAM5 silencing on the malignant behavior of pancreatic cancer cells. circCEACAM5 interacted with DKC1, and DKC1 overexpression reversed the effects ofcircCEACAM5 knockdown on the malignant behavior of pancreatic cancer cells. Conclusion METTL3-mediated m6A methylation of circCEACAM5 drives pancreatic cancer progression by increasing DKC1 expression, suggesting potential new therapeutic targets for this aggressive malignancy.  \nKeywords Pancreatic cancer · M6A methylation · CircCEACAM5 · METTL3 · DKC1  \nBackground  \nPancreatic cancer is a serious malignancy of the digestive system that ranks third in terms of cancer-related deaths [1] . The incidence of pancreatic cancer is increasing annually, and it is likely to be the second most common tumor by 2030 [2], causing a considerable burden on global health and  \n* Tushuai Li[litushuai@cslg.edu.cn](litushuai@cslg.edu.cn)  \n1 School of Biology and Food Engineering, Changshu Institute of Technology, Suzhou 215500, People’s Republic of China  \n2 Jining First People’s Hospital, Jining Medical University, Jining 272000, People’s Republic of China  \n3 MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, People’s Republic of China  \neconomies. The onset of pancreatic cancer is insidious; only 15%−20% of patients with pancreatic cancer are eligible for radical surgery, and the 5-year survival rate is less than 9%  \n[3]. Because pancreatic cancer is prone to early metastasis, it is not sensitive to traditional radiotherapy and chemotherapy, and the treatment methods are limited, so the mortality rate is high. Therefore, studying the pathogenesis of pancreatic cancer is crucial for the development of new treatments [4] .  \nOver the past decade, circular RNAs (circRNAs), a major class of noncoding RNA molecules, have played key roles in the onset and progression of cancer through different mechanisms of action [5] . CircRNAs are closed circular transcripts formed via alternative splicing of precursor mRNAs [6] . CircRNAs are highly abundant, highly stable, sequentially conserved, and specif","cbCaigenrZr3Mndy","https://ap.wps.com/l/cbCaigenrZr3Mndy","pdf",9232633,15,"English","# Abstract\n# Background\n## Pancreatic cancer burden and treatment limitations\n## Roles of circular RNAs in cancer progression\n## Roles of m6A methylation in tumor biology\n# Methods","[{\"question\":\"What role does circCEACAM5 play in pancreatic cancer progression?\",\"answer\":\"circCEACAM5 is significantly upregulated in pancreatic cancer and is associated with poor clinical outcomes. It promotes proliferation, invasion, and migration while inhibiting apoptosis in vitro and in vivo.\"},{\"question\":\"How is circCEACAM5 regulated at the epigenetic level in this study?\",\"answer\":\"METTL3-mediated m6A methylation of circCEACAM5 was confirmed. METTL3 knockdown reverses the malignant effects caused by circCEACAM5 silencing.\"},{\"question\":\"How does DKC1 fit into the circCEACAM5 mechanism?\",\"answer\":\"circCEACAM5 interacts with DKC1. DKC1 overexpression reverses the effects of circCEACAM5 knockdown on malignant behaviors of pancreatic cancer cells.\"}]","METTL3-dependent m6A methylation of circCEACAM5 fuels pancreatic cancer progression through DKC1 activation | PDF",1790188323,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0462eb1df31b855894dca72f592fe1ea.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de3d59969933796d5552b1575ff1c565.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f85293c6ebbb36d1086c7d3399ba0b0e.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11b96d41f06b8d7d601d3a97b91afaa0.webp",980,1301]